Nucleic acid respiratory syncytial virus vaccines

Details Nucleic acid respiratory syncytial virus vaccines Nucleic acid respiratory syncytial virus vaccines

1999-03-05

2000-07-04

Schwartzman, Robert A.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Carbohydrate doai

435 914, C12N 1564, A61K 3170

Patent

active

060839252

ABSTRACT:
Non-replicating vectors containing a nucleotide sequence coding for an F protein of respiratory syncytial virus (RSV) and a promoter for such sequence, preferably a cytomegalovirus promoter, are described for in vivo immunization. The nucleotide sequence encloding the RSV F protein may lack a sequence encoding the homologous signal peptide but possessing a heterologous signal peptide enhancing RSV F protein expression. Such non-replicating vectors, including plasmids, also may contain a further nucleotide sequence located adjacent to the RSV F protein encoding sequence to enhance the immunoprotective ability of the RSV F protein when expressed in vivo. Such non-replicating vectors may be used to immunize a host against disease caused by infection with RSV, including a human host, by administration thereto, and may be formulated as immunogenic compositions with pharmaceutically-acceptable carriers for such purpose. Such vectors also may be used to produce antibodies for detection of RSV infection in a sample.

REFERENCES:
patent: 5149650 (1992-09-01), Wertz et al.
patent: 5589466 (1996-12-01), Felgner et al.
Katz, S.L.New Vaccine Development establishing priorities. vol. 1. Washington: National Academic Press: 1985 397-409.
Pemberton et al., J. Gen. Virol. 1987, 68:2177-2182.
Pizzorno et al., J. Virol. Acids Res. 1988, G2:1167-1179.
Green, S. et al., Nucl. Acids Res. 1988, 16:369.
Breathnack, R. et al., Nucl. Acids Res. 1983, 11:7119-7136.
Karasuyama & Melchers, Eur. J. Immunol. 18, 97-104, 1988.
Wilde, David B. et al., 1983, J. Immunol. 131:2178-2183.
Ledbetter, J.A. et al 1980, J. Exp. Med. 152:280-295.
Ozato Keiko et al, 1982, Transplantation 34:113-118.
Prince et al, J. Virol., 61:1851-1854. (1987).
Hemming et al, J. Infect. Dis., 152:1083-1087 (1985).
McIntosh, K. Et al In: Fields BN, Knipe, DM, editors. Virology, New York: Raven Press 1990:1045-1072.
Wertz, G.W. et al, Biotechnology 1992, 20:151-176.
Johnson et al., J. Virol. 1987, 61: 3163-3165.
Crowe, J.E., Vaccine 1995, 13:415-421.
Ulmer, Current Opinion, Invest Drugs, 1993, 2:983-989.
Tang et al., Nature 1992, 356: 152-154.
Furth et al. Analytical Biochemistry, 1992, 205: 365-368.
Chapman, B.S. et al, Nucl. Acids Res. 1991, 19: 3979-3986.
Graham, B.S. et al., J. Mod. Virol. 1988 26: 153-162.
Nabel, G.J. et al Proc. Natl. Acad. Sci. USA 90:11307-11311 (1993).
Du, R.P. et al 1994, Biotechnology 12: 813-818.
Prince, G.A. et al, 1978. Ame J. Pathol. 93: 771-790.
Davis et al, Vaccine 1994, 12: 1503-1509.
Chanock, Robert M. et al, Pediatrics vol. 90 No. 1, July 1992, pp 137-142.
Prince et al, J. Virol. 55:517;1985 Virus Res. 3; 193-206.
Groothuis et al, N. Engl. J. Med. 329:1524-1530, (1993).
Walsh et al, J. Infec. Dis., 155: 1198-1204, (1987)
Paradiso et al, Pediatr. Infect. Dis. J. 13:792-798, (1994).
Lounsbach et al, Journal of General Virology 74, 2559-2565 (1993).
Wathen et al, J. Infect. Dis. 159: 255-264 (1989).
Wertz et al, J. Virol 61: 293-301 (1987).
Tang et al (1993) J. Biol. Chem. 268:9522-9525.
Collis et al (1990) Embo J. 9:233-240.

Affiliated with

Also associated with

Rating

Nucleic acid respiratory syncytial virus vaccines does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Nucleic acid respiratory syncytial virus vaccines, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nucleic acid respiratory syncytial virus vaccines will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1486706